CN116990512B - 一种基质金属蛋白酶-9检测试剂盒 - Google Patents
一种基质金属蛋白酶-9检测试剂盒 Download PDFInfo
- Publication number
- CN116990512B CN116990512B CN202311238242.XA CN202311238242A CN116990512B CN 116990512 B CN116990512 B CN 116990512B CN 202311238242 A CN202311238242 A CN 202311238242A CN 116990512 B CN116990512 B CN 116990512B
- Authority
- CN
- China
- Prior art keywords
- matrix metalloproteinase
- solution
- antibody
- colloidal gold
- kit
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 108010015302 Matrix metalloproteinase-9 Proteins 0.000 title claims abstract description 79
- 238000001514 detection method Methods 0.000 title claims abstract description 79
- 102000001776 Matrix metalloproteinase-9 Human genes 0.000 title claims abstract description 74
- PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 claims abstract description 85
- FJKROLUGYXJWQN-UHFFFAOYSA-N 4-hydroxybenzoic acid Chemical compound OC(=O)C1=CC=C(O)C=C1 FJKROLUGYXJWQN-UHFFFAOYSA-N 0.000 claims abstract description 24
- 239000000725 suspension Substances 0.000 claims abstract description 22
- 108091003079 Bovine Serum Albumin Proteins 0.000 claims abstract description 20
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims abstract description 20
- 229930006000 Sucrose Natural products 0.000 claims abstract description 20
- 229940098773 bovine serum albumin Drugs 0.000 claims abstract description 20
- 239000005720 sucrose Substances 0.000 claims abstract description 20
- 239000001397 quillaja saponaria molina bark Substances 0.000 claims abstract description 13
- 229930182490 saponin Natural products 0.000 claims abstract description 13
- 150000007949 saponins Chemical class 0.000 claims abstract description 13
- 229940090248 4-hydroxybenzoic acid Drugs 0.000 claims abstract description 12
- 239000002253 acid Substances 0.000 claims abstract description 12
- 230000028327 secretion Effects 0.000 claims abstract description 5
- 239000000243 solution Substances 0.000 claims description 66
- 238000006243 chemical reaction Methods 0.000 claims description 35
- 238000002360 preparation method Methods 0.000 claims description 24
- 238000003908 quality control method Methods 0.000 claims description 20
- 238000012360 testing method Methods 0.000 claims description 20
- 239000007853 buffer solution Substances 0.000 claims description 18
- 241000283707 Capra Species 0.000 claims description 10
- 108060003951 Immunoglobulin Proteins 0.000 claims description 10
- NBZBKCUXIYYUSX-UHFFFAOYSA-N iminodiacetic acid Chemical compound OC(=O)CNCC(O)=O NBZBKCUXIYYUSX-UHFFFAOYSA-N 0.000 claims description 10
- 102000018358 immunoglobulin Human genes 0.000 claims description 10
- 238000000034 method Methods 0.000 claims description 10
- 230000000903 blocking effect Effects 0.000 claims description 9
- 239000002244 precipitate Substances 0.000 claims description 9
- 239000001509 sodium citrate Substances 0.000 claims description 9
- 239000006228 supernatant Substances 0.000 claims description 9
- HRXKRNGNAMMEHJ-UHFFFAOYSA-K trisodium citrate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O HRXKRNGNAMMEHJ-UHFFFAOYSA-K 0.000 claims description 9
- 229940038773 trisodium citrate Drugs 0.000 claims description 9
- 208000003556 Dry Eye Syndromes Diseases 0.000 claims description 6
- 206010013774 Dry eye Diseases 0.000 claims description 6
- 239000003153 chemical reaction reagent Substances 0.000 claims description 5
- 238000002372 labelling Methods 0.000 claims description 5
- 210000001742 aqueous humor Anatomy 0.000 claims description 2
- 238000003556 assay Methods 0.000 claims description 2
- 238000001816 cooling Methods 0.000 claims description 2
- 239000000047 product Substances 0.000 claims description 2
- 238000003149 assay kit Methods 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 230000035945 sensitivity Effects 0.000 abstract description 16
- 208000005494 xerophthalmia Diseases 0.000 abstract description 6
- -1 brij Substances 0.000 abstract description 3
- 239000000872 buffer Substances 0.000 description 25
- 230000000052 comparative effect Effects 0.000 description 18
- 238000005507 spraying Methods 0.000 description 15
- 239000010931 gold Substances 0.000 description 14
- 229910052737 gold Inorganic materials 0.000 description 14
- 238000001035 drying Methods 0.000 description 12
- 238000010521 absorption reaction Methods 0.000 description 11
- 239000007788 liquid Substances 0.000 description 10
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 229920001213 Polysorbate 20 Polymers 0.000 description 8
- 210000000744 eyelid Anatomy 0.000 description 8
- 239000000256 polyoxyethylene sorbitan monolaurate Substances 0.000 description 8
- 235000010486 polyoxyethylene sorbitan monolaurate Nutrition 0.000 description 8
- 238000007789 sealing Methods 0.000 description 8
- 239000000020 Nitrocellulose Substances 0.000 description 6
- 239000000835 fiber Substances 0.000 description 6
- 239000003365 glass fiber Substances 0.000 description 6
- 239000012528 membrane Substances 0.000 description 6
- 238000002156 mixing Methods 0.000 description 6
- 229920001220 nitrocellulos Polymers 0.000 description 6
- 102000002274 Matrix Metalloproteinases Human genes 0.000 description 5
- 108010000684 Matrix Metalloproteinases Proteins 0.000 description 5
- 102100030412 Matrix metalloproteinase-9 Human genes 0.000 description 5
- 210000001508 eye Anatomy 0.000 description 5
- GNBHRKFJIUUOQI-UHFFFAOYSA-N fluorescein Chemical compound O1C(=O)C2=CC=CC=C2C21C1=CC=C(O)C=C1OC1=CC(O)=CC=C21 GNBHRKFJIUUOQI-UHFFFAOYSA-N 0.000 description 5
- 239000011159 matrix material Substances 0.000 description 5
- 239000012086 standard solution Substances 0.000 description 5
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 4
- 239000004327 boric acid Substances 0.000 description 4
- 210000005252 bulbus oculi Anatomy 0.000 description 4
- 239000004005 microsphere Substances 0.000 description 4
- 108091023037 Aptamer Proteins 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 3
- 108090000790 Enzymes Proteins 0.000 description 3
- XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 3
- 229910052782 aluminium Inorganic materials 0.000 description 3
- 238000009835 boiling Methods 0.000 description 3
- 238000005119 centrifugation Methods 0.000 description 3
- 239000011888 foil Substances 0.000 description 3
- 210000003128 head Anatomy 0.000 description 3
- 238000011068 loading method Methods 0.000 description 3
- 229920001690 polydopamine Polymers 0.000 description 3
- 238000003756 stirring Methods 0.000 description 3
- 229910021642 ultra pure water Inorganic materials 0.000 description 3
- 239000012498 ultrapure water Substances 0.000 description 3
- BGXNGARHYXNGPK-UHFFFAOYSA-N 2-[1-[(4-methoxyphenyl)methylsulfanyl]cyclohexyl]acetic acid Chemical compound C1=CC(OC)=CC=C1CSC1(CC(O)=O)CCCCC1 BGXNGARHYXNGPK-UHFFFAOYSA-N 0.000 description 2
- QKNYBSVHEMOAJP-UHFFFAOYSA-N 2-amino-2-(hydroxymethyl)propane-1,3-diol;hydron;chloride Chemical compound Cl.OCC(N)(CO)CO QKNYBSVHEMOAJP-UHFFFAOYSA-N 0.000 description 2
- GHCZTIFQWKKGSB-UHFFFAOYSA-N 2-hydroxypropane-1,2,3-tricarboxylic acid;phosphoric acid Chemical compound OP(O)(O)=O.OC(=O)CC(O)(C(O)=O)CC(O)=O GHCZTIFQWKKGSB-UHFFFAOYSA-N 0.000 description 2
- BTBUEUYNUDRHOZ-UHFFFAOYSA-N Borate Chemical compound [O-]B([O-])[O-] BTBUEUYNUDRHOZ-UHFFFAOYSA-N 0.000 description 2
- 102000003846 Carbonic anhydrases Human genes 0.000 description 2
- 108090000209 Carbonic anhydrases Proteins 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 102000002737 Heme Oxygenase-1 Human genes 0.000 description 2
- 108010018924 Heme Oxygenase-1 Proteins 0.000 description 2
- 206010061218 Inflammation Diseases 0.000 description 2
- 108010016165 Matrix Metalloproteinase 2 Proteins 0.000 description 2
- 102000000424 Matrix Metalloproteinase 2 Human genes 0.000 description 2
- 108010016160 Matrix Metalloproteinase 3 Proteins 0.000 description 2
- 206010052143 Ocular discomfort Diseases 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 102100030416 Stromelysin-1 Human genes 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 239000011324 bead Substances 0.000 description 2
- 230000004064 dysfunction Effects 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000002474 experimental method Methods 0.000 description 2
- 238000011010 flushing procedure Methods 0.000 description 2
- 230000004054 inflammatory process Effects 0.000 description 2
- 239000008363 phosphate buffer Substances 0.000 description 2
- 239000002504 physiological saline solution Substances 0.000 description 2
- 208000024891 symptom Diseases 0.000 description 2
- 230000002123 temporal effect Effects 0.000 description 2
- 208000017667 Chronic Disease Diseases 0.000 description 1
- 102000016911 Deoxyribonucleases Human genes 0.000 description 1
- 108010053770 Deoxyribonucleases Proteins 0.000 description 1
- 108700024394 Exon Proteins 0.000 description 1
- 108091092195 Intron Proteins 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- 230000002159 abnormal effect Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 210000000349 chromosome Anatomy 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000011248 coating agent Substances 0.000 description 1
- 238000000576 coating method Methods 0.000 description 1
- 230000003247 decreasing effect Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 210000002919 epithelial cell Anatomy 0.000 description 1
- 210000003560 epithelium corneal Anatomy 0.000 description 1
- 239000003889 eye drop Substances 0.000 description 1
- 229940012356 eye drops Drugs 0.000 description 1
- 238000003018 immunoassay Methods 0.000 description 1
- 238000003317 immunochromatography Methods 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 230000037456 inflammatory mechanism Effects 0.000 description 1
- 230000001788 irregular Effects 0.000 description 1
- 239000006249 magnetic particle Substances 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- 239000000203 mixture Substances 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 108091008104 nucleic acid aptamers Proteins 0.000 description 1
- 230000003287 optical effect Effects 0.000 description 1
- 230000003204 osmotic effect Effects 0.000 description 1
- 238000004806 packaging method and process Methods 0.000 description 1
- 239000002245 particle Substances 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 229920000136 polysorbate Polymers 0.000 description 1
- 239000011148 porous material Substances 0.000 description 1
- TYJJADVDDVDEDZ-UHFFFAOYSA-M potassium hydrogencarbonate Chemical compound [K+].OC([O-])=O TYJJADVDDVDEDZ-UHFFFAOYSA-M 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 238000005070 sampling Methods 0.000 description 1
- 238000010186 staining Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000004347 surface barrier Methods 0.000 description 1
- MPLHNVLQVRSVEE-UHFFFAOYSA-N texas red Chemical class [O-]S(=O)(=O)C1=CC(S(Cl)(=O)=O)=CC=C1C(C1=CC=2CCCN3CCCC(C=23)=C1O1)=C2C1=C(CCC1)C3=[N+]1CCCC3=C2 MPLHNVLQVRSVEE-UHFFFAOYSA-N 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 230000000007 visual effect Effects 0.000 description 1
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/573—Immunoassay; Biospecific binding assay; Materials therefor for enzymes or isoenzymes
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/543—Immunoassay; Biospecific binding assay; Materials therefor with an insoluble carrier for immobilising immunochemicals
- G01N33/54366—Apparatus specially adapted for solid-phase testing
- G01N33/54386—Analytical elements
- G01N33/54387—Immunochromatographic test strips
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/558—Immunoassay; Biospecific binding assay; Materials therefor using diffusion or migration of antigen or antibody
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Immunology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Molecular Biology (AREA)
- Biomedical Technology (AREA)
- Chemical & Material Sciences (AREA)
- Hematology (AREA)
- Urology & Nephrology (AREA)
- Biotechnology (AREA)
- Microbiology (AREA)
- Cell Biology (AREA)
- Food Science & Technology (AREA)
- Medicinal Chemistry (AREA)
- Physics & Mathematics (AREA)
- Analytical Chemistry (AREA)
- Biochemistry (AREA)
- General Health & Medical Sciences (AREA)
- General Physics & Mathematics (AREA)
- Pathology (AREA)
- Investigating Or Analysing Biological Materials (AREA)
Abstract
Description
Claims (7)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311238242.XA CN116990512B (zh) | 2023-09-25 | 2023-09-25 | 一种基质金属蛋白酶-9检测试剂盒 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202311238242.XA CN116990512B (zh) | 2023-09-25 | 2023-09-25 | 一种基质金属蛋白酶-9检测试剂盒 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN116990512A CN116990512A (zh) | 2023-11-03 |
CN116990512B true CN116990512B (zh) | 2023-12-08 |
Family
ID=88528656
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202311238242.XA Active CN116990512B (zh) | 2023-09-25 | 2023-09-25 | 一种基质金属蛋白酶-9检测试剂盒 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN116990512B (zh) |
Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101802013A (zh) * | 2007-07-16 | 2010-08-11 | 健泰科生物技术公司 | 人源化抗cd79b抗体和免疫偶联物及使用方法 |
CN104841381A (zh) * | 2015-04-28 | 2015-08-19 | 中国农业科学院上海兽医研究所 | 定向吸附载体、免疫亲和层析柱、制备方法和试剂盒 |
CN105624128A (zh) * | 2014-11-26 | 2016-06-01 | 南京博优康远生物医药科技有限公司 | 一种固定化单胺氧化酶及其在合成手性氮杂双环化合物中的应用 |
CN107045062A (zh) * | 2017-03-28 | 2017-08-15 | 广州瑞博奥生物科技有限公司 | 检测人ngal的胶体金免疫层析试纸条、试剂盒及其制备方法 |
CN110118874A (zh) * | 2019-05-30 | 2019-08-13 | 三诺生物传感股份有限公司 | 一种胶体金重悬液、胶体金试剂、胶体金试剂的制备方法与应用 |
CN110702763A (zh) * | 2019-10-26 | 2020-01-17 | 安徽省三车节能科技有限公司 | 一种提高生物传感器检测灵敏度的方法 |
CN111551512A (zh) * | 2020-06-11 | 2020-08-18 | 安徽大千生物工程有限公司 | 一种高灵敏度和特异度的sdLDL-C比色法检测试剂盒及其制备使用方法 |
CN111896732A (zh) * | 2020-08-04 | 2020-11-06 | 武汉生之源生物科技股份有限公司 | 一种胶体金标记方法及其产品 |
CN113881636A (zh) * | 2020-07-03 | 2022-01-04 | 沈剑萍 | 一种游离细胞标记及分离探针及其相关产品和用途 |
WO2022037010A1 (zh) * | 2020-08-21 | 2022-02-24 | 北京现代高达生物技术有限责任公司 | 一种新型冠状病毒s蛋白和n蛋白联合检测胶体金试纸条及其制备方法和用途 |
CN114315784A (zh) * | 2021-11-30 | 2022-04-12 | 浙江工业大学 | 一种组氨酸标签荧光探针及其制备方法和应用 |
CN114829604A (zh) * | 2019-10-16 | 2022-07-29 | 中外制药株式会社 | 抗体、药物组合物和方法 |
CN115015547A (zh) * | 2021-12-30 | 2022-09-06 | 上海云泽生物科技有限公司 | 低位阻胶乳增强免疫竞争法定量测定全血中他克莫司的试剂盒 |
CN115141384A (zh) * | 2022-06-30 | 2022-10-04 | 五邑大学 | 一种高强韧、高灵敏度、自粘附的导电水凝胶的制备方法 |
CN217787113U (zh) * | 2022-08-09 | 2022-11-11 | 江西乐成生物医疗有限公司 | 一种基质金属蛋白酶-3胶体金免疫快速检测试剂板 |
CN115651964A (zh) * | 2022-10-14 | 2023-01-31 | 华中科技大学 | 一种磁性探针及制备与检测基质金属蛋白酶的应用 |
CN115815583A (zh) * | 2022-12-16 | 2023-03-21 | 国纳之星(上海)纳米科技发展有限公司 | 一种表面改性的纳米金颗粒gns@pei-cooh的制备方法及产品和应用 |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2996003B1 (fr) * | 2012-09-25 | 2014-10-17 | Commissariat Energie Atomique | Methode pour detecter specifiquement dans un echantillon une metalloprotease matricielle (mmp) d'interet uniquement dans sa forme active |
-
2023
- 2023-09-25 CN CN202311238242.XA patent/CN116990512B/zh active Active
Patent Citations (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101802013A (zh) * | 2007-07-16 | 2010-08-11 | 健泰科生物技术公司 | 人源化抗cd79b抗体和免疫偶联物及使用方法 |
CN105624128A (zh) * | 2014-11-26 | 2016-06-01 | 南京博优康远生物医药科技有限公司 | 一种固定化单胺氧化酶及其在合成手性氮杂双环化合物中的应用 |
CN104841381A (zh) * | 2015-04-28 | 2015-08-19 | 中国农业科学院上海兽医研究所 | 定向吸附载体、免疫亲和层析柱、制备方法和试剂盒 |
CN107045062A (zh) * | 2017-03-28 | 2017-08-15 | 广州瑞博奥生物科技有限公司 | 检测人ngal的胶体金免疫层析试纸条、试剂盒及其制备方法 |
CN110118874A (zh) * | 2019-05-30 | 2019-08-13 | 三诺生物传感股份有限公司 | 一种胶体金重悬液、胶体金试剂、胶体金试剂的制备方法与应用 |
CN114829604A (zh) * | 2019-10-16 | 2022-07-29 | 中外制药株式会社 | 抗体、药物组合物和方法 |
CN110702763A (zh) * | 2019-10-26 | 2020-01-17 | 安徽省三车节能科技有限公司 | 一种提高生物传感器检测灵敏度的方法 |
CN111551512A (zh) * | 2020-06-11 | 2020-08-18 | 安徽大千生物工程有限公司 | 一种高灵敏度和特异度的sdLDL-C比色法检测试剂盒及其制备使用方法 |
CN113881636A (zh) * | 2020-07-03 | 2022-01-04 | 沈剑萍 | 一种游离细胞标记及分离探针及其相关产品和用途 |
CN111896732A (zh) * | 2020-08-04 | 2020-11-06 | 武汉生之源生物科技股份有限公司 | 一种胶体金标记方法及其产品 |
WO2022037010A1 (zh) * | 2020-08-21 | 2022-02-24 | 北京现代高达生物技术有限责任公司 | 一种新型冠状病毒s蛋白和n蛋白联合检测胶体金试纸条及其制备方法和用途 |
CN114315784A (zh) * | 2021-11-30 | 2022-04-12 | 浙江工业大学 | 一种组氨酸标签荧光探针及其制备方法和应用 |
CN115015547A (zh) * | 2021-12-30 | 2022-09-06 | 上海云泽生物科技有限公司 | 低位阻胶乳增强免疫竞争法定量测定全血中他克莫司的试剂盒 |
CN115141384A (zh) * | 2022-06-30 | 2022-10-04 | 五邑大学 | 一种高强韧、高灵敏度、自粘附的导电水凝胶的制备方法 |
CN217787113U (zh) * | 2022-08-09 | 2022-11-11 | 江西乐成生物医疗有限公司 | 一种基质金属蛋白酶-3胶体金免疫快速检测试剂板 |
CN115651964A (zh) * | 2022-10-14 | 2023-01-31 | 华中科技大学 | 一种磁性探针及制备与检测基质金属蛋白酶的应用 |
CN115815583A (zh) * | 2022-12-16 | 2023-03-21 | 国纳之星(上海)纳米科技发展有限公司 | 一种表面改性的纳米金颗粒gns@pei-cooh的制备方法及产品和应用 |
Non-Patent Citations (1)
Title |
---|
一种基于酶标纳米金探针的蛋白质检测方法;钟晓琴;刘美英;黄云艳;贾春平;金庆辉;赵建龙;李凤民;;中国医药生物技术(第03期);第200-206页 * |
Also Published As
Publication number | Publication date |
---|---|
CN116990512A (zh) | 2023-11-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EP0362809B1 (en) | Device and method for the detection of an analyte | |
Chan | A superior early myocardial infarction marker: human heart-type fatty acid-binding protein | |
US6764849B2 (en) | Rapid diagnostic method for distinguishing allergies and infections and nasal secretion collection unit | |
EP1381864B1 (en) | Detection of candida | |
WO2019174165A1 (zh) | hCG周期检测试纸、试剂盒及其制备方法、应用 | |
CN112485436A (zh) | 检测新冠疫苗注射后体内中和抗体的胶体金免疫层析试纸条及其制备方法 | |
WO2021012999A1 (zh) | 一种试剂卡、检测方法及应用 | |
CN113834944B (zh) | 一种红细胞中叶酸的量子点荧光检测方法 | |
CN219302476U (zh) | 一种多联检测装置 | |
CN116990512B (zh) | 一种基质金属蛋白酶-9检测试剂盒 | |
JP3304214B2 (ja) | 簡易測定方法及び簡易測定装置 | |
CN117452002B (zh) | 一种尿液唾液同检的人绒毛膜促性腺激素胶体金检测试纸条及试剂盒 | |
CN117250352B (zh) | 胃蛋白酶检测试剂盒 | |
AU695935B2 (en) | Sampling kit for obtaining lacrimal fluid | |
US20090263905A1 (en) | Detection test assembly for detecting the presence of a substance in a sample | |
CN106932592B (zh) | 检测人表面活性蛋白a的胶体金试纸条及其制备方法和应用 | |
EP0770875B1 (en) | Marker and reagent for diabetes mellitus and diabetes mellitus complication | |
CN113252909B (zh) | 一种基于量子点免疫荧光检测试剂盒制备方法 | |
CN110456044B (zh) | 一种用于前列腺炎检测的试剂盒 | |
CN114034857A (zh) | 一种利用双抗夹心法快速半定量检测血清铁蛋白的胶体金免疫层析试纸条的制备方法 | |
CN208818724U (zh) | 一种快速定量检测il-6和pct的免疫荧光层析试剂盒 | |
EP1256802B1 (en) | Method for examination of feces occult blood | |
CN112485449A (zh) | 一种检测猫saa的斑点免疫金渗滤试剂盒及半定量检测方法 | |
CN210894376U (zh) | 一种快速检测人血中弓形虫IgG的试纸条 | |
EP0756173A1 (en) | Reagent for detecting substances and method for diagnosing rheumatoid arthritis |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
TR01 | Transfer of patent right |
Effective date of registration: 20240117 Address after: Room 601, Building B, No. 1112 Yunzheng Avenue, Baiyun District, Guangzhou City, Guangdong Province, 510445 Patentee after: Guangdong Jucheng Biotechnology Co.,Ltd. Address before: Room 210, 2nd Floor, Building 1, No. 28 Yongxing Road, Daxing Biopharmaceutical Industry Base, Zhongguancun Science and Technology Park, Daxing District, Beijing 102600 Patentee before: Jucheng (Beijing) Biotechnology Co.,Ltd. Patentee before: Guangdong Jucheng Biotechnology Co.,Ltd. |
|
TR01 | Transfer of patent right |